Heart & Lung News
Launch of Xenios console & Novalung patient kits in South Korea
Happy to share some great news! Fresenius Medical Care announced the launch of the Xenios console and Novalung patient kits in South Korea! The introduction of heart and lung therapies expands Fresenius Medical Care’s portfolio in South Korea to multi-organ support. The Xenios console was approved by the Ministry of Food and Drug ...
EPNV congress 2021
We participated in EPNV congress (European Conference on Pediatric and Neonatal Mechanical Ventilation) in Montreux, October 27 – 30, 2021. The congress was held in a hybrid format (in-person and online). We where part of the online part of the congress with our virtual ICU, as well as in-person with a sponsored workshop: WORKSHOP 3 ...
EACTAIC virtual congress 2021
This year, we participated in EACTAIC (European Association of Cardiothoracic Anaesthesiology and Intensive Care) virtual meeting, October 27 – 29, 2021. We sponsored and supported a symposium on the topic of icor: Synchronized Cardiac Support – A new option in VA ECMO | October 27th | 02:00 – 02:45 pm: VA ...
ESICM LIVES virtual congress 2021
Xenios took part at ESICM LIVES from 03-06 October 2021! To ensure that everyone can participate, LIVES 2021 was again a fully digital event. The congress offered discussions and debates, abstract presentations, scientific sessions, live votings and demonstrations. We again presented our virtual ICU to show our product and treatment portfolio ...
First installation & training session in China
Happy to share some good news! The first installation and training session with the Xenios console in China mainland was successfully completed. Thanks to the Fresenius Medical Care China & Fresenius Medical Care Asia-Pacific Team for their effort and passion!
ISICEM virtual congress 2021
Xenios took part in ISICEM virtual congress, August 31 - September 03, 2021. We showed our treatment and product portfolio in our virtual ICU via a VV ECMO patient case. Get an idea about our virtual ICU: http://ow.ly/kbkr50FWbTl